Dimerix Limited (DXB.AX)
AUD 0.32
(-5.88%)
AUD 0.32
(-5.88%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -21.99 Million AUD | -981.22% |
| 2023 | -2.03 Million AUD | 78.72% |
| 2022 | -9.55 Million AUD | -4516.72% |
| 2021 | -207 Thousand AUD | 96.92% |
| 2020 | -6.73 Million AUD | -88.88% |
| 2019 | -3.56 Million AUD | 43.3% |
| 2018 | -6.28 Million AUD | -179.99% |
| 2017 | -2.24 Million AUD | -11.18% |
| 2016 | -2.01 Million AUD | 31.13% |
| 2015 | -2.93 Million AUD | -144.43% |
| 2014 | -1.19 Million AUD | -4.06% |
| 2013 | -1.15 Million AUD | -646.79% |
| 2012 | -154.32 Thousand AUD | 85.04% |
| 2011 | -1.03 Million AUD | 11.35% |
| 2010 | -1.16 Million AUD | -213.18% |
| 2009 | -371.67 Thousand AUD | -141.3% |
| 2008 | 899.85 Thousand AUD | -45.91% |
| 2007 | 1.66 Million AUD | 247.99% |
| 2006 | -1.12 Million AUD | 49.5% |
| 2005 | -2.22 Million AUD | -438.32% |
| 2004 | 658 Thousand AUD | 35.39% |
| 2003 | 486 Thousand AUD | 10.71% |
| 2002 | 439 Thousand AUD | 385.06% |
| 2001 | -154 Thousand AUD | -110.58% |
| 2000 | 1.45 Million AUD | -22.18% |
| 1999 | 1.87 Million AUD | 30.2% |
| 1998 | 1.43 Million AUD | 1532.95% |
| 1997 | 88 Thousand AUD | -44.53% |
| 1996 | 158.63 Thousand AUD | 6.46% |
| 1995 | 149 Thousand AUD | 28.45% |
| 1994 | 116 Thousand AUD | 5700.0% |
| 1993 | 2000.00 AUD | 101.06% |
| 1992 | -189 Thousand AUD | -921.74% |
| 1991 | 23 Thousand AUD | 675.0% |
| 1990 | -4000.00 AUD | 80.95% |
| 1989 | -21 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -13.38 Million AUD | 0.0% |
| 2024 Q4 | -21.99 Million AUD | 0.0% |
| 2024 FY | -21.99 Million AUD | -981.22% |
| 2023 Q4 | -2.03 Million AUD | 0.0% |
| 2023 Q2 | -5.66 Million AUD | 0.0% |
| 2023 FY | -2.03 Million AUD | 78.72% |
| 2022 FY | -9.55 Million AUD | -4516.72% |
| 2022 Q2 | -16.24 Million AUD | 0.0% |
| 2022 Q4 | -9.55 Million AUD | 0.0% |
| 2021 Q2 | -4.86 Million AUD | 0.0% |
| 2021 Q4 | -207 Thousand AUD | 0.0% |
| 2021 FY | -207 Thousand AUD | 96.92% |
| 2020 Q2 | -3.84 Million AUD | 0.0% |
| 2020 FY | -6.73 Million AUD | -88.88% |
| 2020 Q4 | -6.73 Million AUD | 0.0% |
| 2019 FY | -3.56 Million AUD | 43.3% |
| 2019 Q4 | -3.56 Million AUD | 0.0% |
| 2019 Q2 | -5.32 Million AUD | 0.0% |
| 2018 FY | -6.28 Million AUD | -179.99% |
| 2018 Q4 | -6.28 Million AUD | 0.0% |
| 2018 Q2 | -1.11 Million AUD | 0.0% |
| 2017 FY | -2.24 Million AUD | -11.18% |
| 2017 Q2 | -1 Million AUD | 0.0% |
| 2017 Q4 | -2.24 Million AUD | 0.0% |
| 2016 Q4 | -2.01 Million AUD | 0.0% |
| 2016 FY | -2.01 Million AUD | 31.13% |
| 2016 Q2 | -2.55 Million AUD | 0.0% |
| 2015 Q3 | -486.86 Thousand AUD | 0.0% |
| 2015 Q4 | -2.93 Million AUD | -502.08% |
| 2015 FY | -2.93 Million AUD | -144.43% |
| 2014 Q4 | -1.19 Million AUD | 0.0% |
| 2014 FY | -1.19 Million AUD | -4.06% |
| 2013 Q4 | -1.15 Million AUD | 0.0% |
| 2013 FY | -1.15 Million AUD | -646.79% |
| 2012 Q4 | -154.32 Thousand AUD | 0.0% |
| 2012 FY | -154.32 Thousand AUD | 85.04% |
| 2011 FY | -1.03 Million AUD | 11.35% |
| 2011 Q4 | -1.03 Million AUD | 0.0% |
| 2010 FY | -1.16 Million AUD | -213.18% |
| 2010 Q4 | -1.16 Million AUD | 0.0% |
| 2009 FY | -371.67 Thousand AUD | -141.3% |
| 2009 Q4 | -371.67 Thousand AUD | 0.0% |
| 2008 Q4 | 899.85 Thousand AUD | 0.0% |
| 2008 FY | 899.85 Thousand AUD | -45.91% |
| 2007 Q4 | 1.66 Million AUD | 0.0% |
| 2007 FY | 1.66 Million AUD | 247.99% |
| 2006 FY | -1.12 Million AUD | 49.5% |
| 2006 Q4 | -1.12 Million AUD | 0.0% |
| 2005 Q4 | -2.22 Million AUD | 0.0% |
| 2005 FY | -2.22 Million AUD | -438.32% |
| 2004 Q4 | 658.35 Thousand AUD | 0.0% |
| 2004 FY | 658 Thousand AUD | 35.39% |
| 2003 Q4 | 485.4 Thousand AUD | 0.0% |
| 2003 FY | 486 Thousand AUD | 10.71% |
| 2002 FY | 439 Thousand AUD | 385.06% |
| 2002 Q4 | 449.59 Thousand AUD | 0.0% |
| 2001 FY | -154 Thousand AUD | -110.58% |
| 2001 Q4 | -153.69 Thousand AUD | 0.0% |
| 2000 Q4 | 1.45 Million AUD | 0.0% |
| 2000 FY | 1.45 Million AUD | -22.18% |
| 1999 FY | 1.87 Million AUD | 30.2% |
| 1999 Q4 | 1.87 Million AUD | 0.0% |
| 1998 FY | 1.43 Million AUD | 1532.95% |
| 1997 Q4 | 83.7 Thousand AUD | 0.0% |
| 1997 FY | 88 Thousand AUD | -44.53% |
| 1996 FY | 158.63 Thousand AUD | 6.46% |
| 1995 FY | 149 Thousand AUD | 28.45% |
| 1994 FY | 116 Thousand AUD | 5700.0% |
| 1993 FY | 2000.00 AUD | 101.06% |
| 1992 FY | -189 Thousand AUD | -921.74% |
| 1991 FY | 23 Thousand AUD | 675.0% |
| 1990 FY | -4000.00 AUD | 80.95% |
| 1989 FY | -21 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -16.366% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -2139.245% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 533.991% |
| Biome Australia Limited | -1.56 Million AUD | -1307.198% |
| Patrys Limited | -2.24 Million AUD | -881.486% |
| Orthocell Limited | -19.92 Million AUD | -10.374% |
| Imugene Limited | -91.56 Million AUD | 75.981% |
| Noxopharm Limited | -2.31 Million AUD | -847.952% |
| PYC Therapeutics Limited | -65.76 Million AUD | 66.558% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -620.333% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -116.397% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -247.759% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -254.396% |
| CSL Limited | 15.76 Billion AUD | 100.14% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -72.967% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2999.364% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 87.982% |
| Starpharma Holdings Limited | -19.83 Million AUD | -10.89% |
| Nanollose Limited | -96.22 Thousand AUD | -22754.542% |
| Memphasys Limited | 4.13 Million AUD | 631.797% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -265.005% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -343.907% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -1105.96% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 72.27% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1675.809% |
| Race Oncology Limited | -17.18 Million AUD | -27.942% |
| Nyrada Inc. | -4.76 Million AUD | -361.104% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 79.212% |
| PharmAust Limited | -9.71 Million AUD | -126.39% |
| Immutep Limited | -122.18 Million AUD | 82.002% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 83.889% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -76.218% |
| BTC Health Limited | -2.02 Million AUD | -987.542% |
| Acrux Limited | -1.45 Million AUD | -1408.353% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -28.652% |
| Biotron Limited | -386.06 Thousand AUD | -5596.35% |
| Tissue Repair Ltd | -16.44 Million AUD | -33.761% |
| AdAlta Limited | -845.17 Thousand AUD | -2502.045% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -18.394% |
| Hexima Limited | -2.22 Million AUD | -887.856% |
| AnteoTech Limited | -5 Million AUD | -339.702% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -25.085% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -547.553% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -312.662% |
| Actinogen Medical Limited | -9.13 Million AUD | -140.83% |
| Immuron Limited | -11.48 Million AUD | -91.502% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -38.203% |